Prediction of periprocedural Bleeding Event during enDoScopIc submucosal DissEction using total thrombus-formation analysis system study
Not Applicable
- Conditions
- early stage cancer in upper gastrointestinal tract
- Registration Number
- JPRN-UMIN000048592
- Lead Sponsor
- Teikyo University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who refuse to participate, emergent cases, patients who changed antithrombotic therapy within seven days of endoscopic submucosal dissection, patients who used heparin as antithrombotic therapy
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hemostasis function assessed by T-TAS, Bleeding events during hospitalization (change of serum hemoglobin level, blood transfusion, unexpected drug withdrawal of antithrombotic drugs), Ischemic events (stroke, myocardial infarction)
- Secondary Outcome Measures
Name Time Method